|
| 36828140 | Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials. | Radiother Oncol | 2023 |
| 37883081 | Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial. | JAMA Oncol | 2023 |
| 37535134 | Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria. | Wien Klin Wochenschr | 2023 |
| 37494589 | Bridging the gap: A quality improvement project to implement psychosocial care standards into clinical practice in pediatric oncology. | Klin Padiatr | 2023 |
| 37219741 | Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. | Clin Exp Metastasis | 2023 |
| 37243889 | Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. | Pediatr Blood Cancer | 2023 |
| 37468069 | Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience. | Radiother Oncol | 2023 |
| 37268767 | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities. | Strahlenther Onkol | 2023 |
| 36858722 | Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study. | Lancet Oncol | 2023 |
| 36640946 | Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee. | Radiother Oncol | 2023 |
| 34342680 | Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature. | J Neurol | 2022 |
| 35397435 | Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study. | ESMO Open | 2022 |
| 35696745 | Corrigendum to 'Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study': [ESMO Open Volume 7, Issue 2, April 2022, 100466]. | ESMO Open | 2022 |
| 35780527 | QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer. | Eur J Cancer | 2022 |
| 36791741 | Presurgical Perspective and Posttreatment Evaluation of Soft Tissue Tumors of the Ankle and Foot in Adults. | Semin Musculoskelet Radiol | 2022 |
| 35941372 | Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. | Nat Med | 2022 |
| 35998208 | Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. | Clin Cancer Res | 2022 |
| 36291912 | Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach. | Cancers (Basel) | 2022 |
| 36051012 | Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia-A population-based analysis of the Austrian ALL-BFM Study Group. | EJHaem | 2022 |
| 35145254 | Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. | Br J Cancer | 2022 |
| 34998049 | Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years. | Eur J Cancer | 2022 |
| 35229396 | Enhanced expression of autophagy-related p62 without increased deposits of neurodegeneration-associated proteins in glioblastoma and surrounding tissue - An autopsy-based study. | Brain Pathol | 2022 |
| 34895479 | Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. | Lancet Oncol | 2022 |
| 34390770 | Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group. | Int J Radiat Oncol Biol Phys | 2022 |
| 34351451 | Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. | Strahlenther Onkol | 2022 |
| 32969745 | Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience. | Acta Oncol | 2021 |
| 33651248 | LAG-3 expression in the inflammatory microenvironment of glioma. | J Neurooncol | 2021 |
| 33540616 | Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94. | Cancers (Basel) | 2021 |
| 33538093 | Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial. | Pediatr Blood Cancer | 2021 |
| 33818890 | Pediatric classical Hodgkin lymphoma. | Pediatr Blood Cancer | 2021 |
| 33896572 | Lung Cancer in Austria. | J Thorac Oncol | 2021 |
| 33588158 | Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases. | ESMO Open | 2021 |
| 34538585 | Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. | Clin Lung Cancer | 2021 |
| 33995593 | Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab. | Ther Adv Med Oncol | 2021 |
| 34098230 | Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases. | ESMO Open | 2021 |
| 34121071 | Androgen Receptor is Expressed in Breast Cancer Brain Metastases. | Appl Immunohistochem Mol Morphol | 2021 |
| 33956203 | Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. | Cancer Immunol Immunother | 2021 |
| 34311004 | Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial. | Radiother Oncol | 2021 |
| 33090244 | Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas. | Acta Neurochir (Wien) | 2021 |
| 33226469 | Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial. | Strahlenther Onkol | 2021 |
| 33186683 | Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. | Radiother Oncol | 2021 |
| 33473170 | Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. | Br J Cancer | 2021 |
| 31431371 | Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. | Radiother Oncol | 2020 |
| 32072145 | Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group. | Hemasphere | 2020 |
| 31767472 | Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. | Radiother Oncol | 2020 |
| 33305077 | Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial. | Adv Radiat Oncol | 2020 |
| 33184096 | Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. | ESMO Open | 2020 |
| 33392079 | Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes. | Front Oncol | 2020 |
| 33353026 | Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma. | J Pers Med | 2020 |
| 33202825 | Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial. | Cancers (Basel) | 2020 |